therapeutic drug monitoring

Alt text: A screenshot of the CMM device description in Nutromics's website
By  Adam Ang 04:34 am August 27, 2021
Nutromics, an Australian medical technology startup, has raised A$5.7 million ($4.1 million) in a pre-market funding round participated by private investors. This brings its total capital raised in the past three years to A$10 million ($7.2 million). WHAT IT DOES Founded in 2018, the startup is developing continuous molecular monitoring (CMM) platform technology that is able to track multiple...